rs79471015

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_005045.4(RELN):​c.416C>T​(p.Thr139Ile) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

RELN
NM_005045.4 missense

Scores

10
9

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 5.70
Variant links:
Genes affected
RELN (HGNC:9957): (reelin) This gene encodes a large secreted extracellular matrix protein thought to control cell-cell interactions critical for cell positioning and neuronal migration during brain development. This protein may be involved in schizophrenia, autism, bipolar disorder, major depression and in migration defects associated with temporal lobe epilepsy. Mutations of this gene are associated with autosomal recessive lissencephaly with cerebellar hypoplasia. Two transcript variants encoding distinct isoforms have been identified for this gene. Other transcript variants have been described but their full length nature has not been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RELNNM_005045.4 linkc.416C>T p.Thr139Ile missense_variant Exon 3 of 65 ENST00000428762.6 NP_005036.2 P78509-1
RELNNM_173054.3 linkc.416C>T p.Thr139Ile missense_variant Exon 3 of 64 NP_774959.1 P78509-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RELNENST00000428762.6 linkc.416C>T p.Thr139Ile missense_variant Exon 3 of 65 5 NM_005045.4 ENSP00000392423.1 P78509-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7 Uncertain:1
May 08, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 139 of the RELN protein (p.Thr139Ile). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with RELN-related conditions. This variant is not present in population databases (gnomAD no frequency). -

Norman-Roberts syndrome Uncertain:1
Dec 27, 2022
Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence variant is a single nucleotide substitution (C>T) at coding position 416 of the RELN gene that results in a threonine to isoleucine amino acid change at residue 139 of the RELN protein product, Reelin. This is a novel variant that has not been reported to databases of clinically annotated variants, or observed in the literature in individuals with RELN-related illness, to our knowledge. This variant is also not observed in the gnomAD population database (0 of ~250,000 alleles). Multiple bioinformatic tools predict that this variant would be damaging, and the Thr139 residue is well conserved across the vertebrate species examined. Functiol studies testing the effect of this variant on protein structure or activity have not been performed, to our knowledge. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider this to be a variant of uncertain significance. ACMG Criteria: PM2, PP3 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.56
BayesDel_addAF
Benign
-0.045
T
BayesDel_noAF
Benign
-0.30
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.097
T;.;.
Eigen
Uncertain
0.60
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.86
D;D;D
M_CAP
Benign
0.015
T
MetaRNN
Uncertain
0.71
D;D;D
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.5
L;L;.
PrimateAI
Uncertain
0.71
T
PROVEAN
Benign
-2.1
N;N;N
REVEL
Benign
0.26
Sift
Uncertain
0.0030
D;D;D
Sift4G
Uncertain
0.0080
D;D;D
Polyphen
0.98
D;D;.
Vest4
0.82
MutPred
0.61
Loss of catalytic residue at T139 (P = 0.0025);Loss of catalytic residue at T139 (P = 0.0025);Loss of catalytic residue at T139 (P = 0.0025);
MVP
0.28
MPC
0.45
ClinPred
0.94
D
GERP RS
5.3
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.6
Varity_R
0.31
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr7-103474041; API